Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Founded in 1998 and headqua…
HQ: Aliso Viejo, CA, United States of Americawww.glaukos.com
USD245.72-0.13%vs prev. close
Performance
1W
+11.84%
1M
+48.66%
3M
+29.87%
1Y
+165.66%
YTD
+117.90%
Valuation
P/E
—
EPS TTM
-2.94
Dividend yield
—
Size and risk
Market cap
$14.6B
Beta
0.68
Price history
GKOS price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Glaukos
GKOS
Medical Devices
Mkt cap (USD bn)
14.6
P/E
—
Div yld
—
1W
+11.8%
1M
+48.7%
3M
+29.9%
6M
+73.1%
1Y
+165.7%
YTD
+117.9%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Glaukos
GKOS
Medical Devices
14.6
—
—
+11.8%
+48.7%
+29.9%
+73.1%
+165.7%
+117.9%
Subscribe to Equity Analytics to compare GKOS with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.